Jle. Gronvall-nordquist et al., Follow-up of plasma semicarbazide-sensitive amine oxidase activity and retinopathy in Type 2 diabetes mellitus, J DIABET C, 15(5), 2001, pp. 250-256
Plasma activity of the enzyme semicarbazide-sensitive amine oxidase (SSAO)
is high in diabetes. Production of angiotoxic substances (an aldehyde, hydr
ogen peroxide, and ammonia) in vessel walls is catalysed by SSAO, suggestin
g a role for SSAO in the development of complications of diabetes. The obje
ctive of the present study was to follow up plasma SSAO activity (measured
radiometrically), HbA(1c) (using ion exchange chromatography), and retinopa
thy (by fundus photography) after 2.8 years, in 34 patients with Type 2 dia
betes. We also measured urinary levels of an SSAO substrate, methylamine, b
y fluorometric high-performance liquid chromatography (HPLC). As at baselin
e, plasma SSAO activity was now higher in subjects with retinopathy (mean 1
9.5) than in subjects without retinopathy (mean 16.0), 95% confidence inter
val (CI) for difference 0.6-6.3 nmol benzylamine ml(-1) plasma h(-1). SSAO
activity had not changed significantly since baseline, mean difference -1.6
5 and 95% CI for difference -3.76 to 0.46 nmol benzylamine ml(-1) plasma h(
-1). Mean HbA(1c) level remained higher for patients with retinopathy (now
7.9%) compared to those without retinopathy (6.1%), 95% CI for difference 0
.6-3.0%. Comparing baseline and the present study, retinopathy was nonproli
ferative; level had worsened for five and improved for two patients. Urinar
y methylamine/creatinine ratio was lower in the group of patients with reti
nopathy (mean 0.99) than in those without retinopathy (mean 1.78), 95% CI f
or difference 0.1-1.5 mug mg(-1). The results of the present study are comp
atible with a role for SSAO in the development of diabetic retinopathy. (C)
2001 Elsevier Science Inc. All rights reserved.